Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1
Open accessThe DOI matches its Crossref record; 169 of the 170 references it cites were found in a registry or an index.
Abstract
Alzheimer’s disease (AD) is a progressive and neurodegenerative disorder of the cortex and hippocampus, which eventually leads to cognitive impairment. Although the etiology of AD remains unclear, the presence of β ‐amyloid (A β ) peptides in these learning and memory regions is a hallmark of AD. Therefore, the inhibition of A β peptide aggregation has been considered the primary therapeutic strategy for AD treatment. Many studies have shown that resveratrol has antioxidant, anti‐inflammatory, and neuroprotective properties and can decrease the toxicity and aggregation of A β peptides in the hippocampus of AD patients, promote neurogenesis, and prevent hippocampal damage. In addition, the antioxidant activity of resveratrol plays an important role in neuronal differentiation through the activation of silent information regulator‐1 (SIRT1). SIRT1 plays a vital role in the growth and differentiation of neurons and prevents the apoptotic death of these neurons by deacetylating and repressing p53 activity; however, the exact mechanisms remain unclear. Resveratrol also has anti‐inflammatory effects as it suppresses M1 microglia activation, which is involved in the initiation of neurodegeneration, and promotes Th2 responses by increasing anti‐inflammatory cytokines and SIRT1 expression. This review will focus on the antioxidant and anti‐inflammatory neuroprotective effects of resveratrol, specifically on its role in SIRT1 and the association with AD pathophysiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Main cellular routes proposed for the mechanisms of resveratrol in Alzheimer's disease. Modified from Ma et al. [72].](https://figures.cochat.ai/paper-figures/298b13e31ae74366bf246f40fc9ced35/neuroprotective-mechanisms-of-resveratrol-in-alzheimers-disease-role-of-sirt1-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Likewise, SIRT1 inhibits Aβ production and neuroinflammation and prevents neuronal apoptosis in AD models.414”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [414]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: SIRT1 Suppresses β-Amyloid Production by Activating the α-Secretase Gene ADAM10
Donmez, G., Wang, D., Cohen, D. E., & Guarente, L. (2010) · Cell · doi:10.1016/j.cell.2010.06.020 · Cited by 432
RetractedMarwarha, G., Raza, S., Meiers, C., & Ghribi, O. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.015 · Cited by 107
RetractedSmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796 · cited 1×
“Some studies have reported that resveratrol is an activator of SIRT1 [27, 69], although further evidence shows that resveratrol is not a direct activator of SIRT1 [70], and that its role may be related to the activation of substrates of SIRT1 [71].”
BackgroundAMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300 · cited 7×
“Some neurodegenerative diseases, such as AD, are associated with oxidative stress and neuroinflammation, and proteins that are closely related to this neurological disorder (i.e., AMPK, SIRT1, and PGC-1α) can be modulated by resveratrol [152]; however, there are few clinical studies on resveratrol in AD patients.”
BackgroundInfluentialModulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750 · cited 1×
“vation and had strong neuroprotective effects [68, 155].”
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · cited 1×
“However, oxidative stress is also an important event in the pathogenesis of AD [89], as the generation and accumulation of ROS and reactive nitrogen species can accelerate fibrillization, increase the toxicity of Aβ, and promote neuronal death and neurodegeneration [90–93].”
BackgroundHIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,880
Price, N. L., Gomes, A. P., Ling, A. J. Y., Duarte, F. V., Martin-Montalvo, A., North, B. J., Agarwal, B., Ye, L., Ramadori, G., Teodoro, J. S., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.003 · Cited by 1,602 · cited 1×
“Thus, showing a dose-dependent effect, resveratrol was able to activate AMPK independently of SIRT1 [116].”
BackgroundResveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Park, S.-J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.017 · Cited by 1,349
Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
Cited by
Items 101–200 of 401
Non-Enzymatic Antioxidants against Alzheimer’s Disease: Prevention, Diagnosis and Therapy
Varesi, A., Campagnoli, L. I. M., Carrara, A., Pola, I., Floris, E., Ricevuti, G., Chirumbolo, S., & Pascale, A. (2023) · Antioxidants · doi:10.3390/antiox12010180 · Cited by 53
Hub Genes, Diagnostic Model, and Predicted Drugs Related to Iron Metabolism in Alzheimer's Disease
Gu, X., Lai, D., Liu, S., Chen, K., Zhang, P., Chen, B., Huang, G., Cheng, X., & Lu, C. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.949083 · Cited by 46
“Resveratrol can improve AD-associated pathologies and produce therapeutic effects (Gomes et al., 2018; Rahman et al., 2020; Yan et al., 2020; Fang et al., 2021; Gu et al., 2021; Jang et al., 2021; Abozaid et al., 2022).”
BackgroundBrain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review
Jalili, C., Kiani, A., Gholami, M., Bahrehmand, F., Fakhri, S., Kakehbaraei, S., & Kakebaraei, S. (2023) · IET Nanobiotechnology · doi:10.1049/nbt2.12127 · Cited by 47
“One of the molecular pathways of RES‐mediated neuroprotection involves the expression of the Sirt1 gene, which can retain neuron cells against oxidation, inflammation, apoptosis, and necrosis [76].”
BackgroundMitochondrial Dysfunction in Alzheimer’s Disease and Progress in Mitochondria-Targeted Therapeutics
Flannery, P. J., & Trushina, E. V. (2019) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-019-00179-0 · Cited by 43
Current Evidence on the Effect of Dietary Polyphenols Intake on Brain Health
D’Angelo, S. (2020) · Current Nutrition & Food Science · doi:10.2174/1573401316999200714160126 · Cited by 45
Talebi, M., Talebi, M., Kakouri, E., Farkhondeh, T., Pourbagher‐Shahri, A. M., Tarantilis, P. Α., & Samarghandian, S. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.042 · Cited by 46
Icariin ameliorate Alzheimer’s disease by influencing SIRT1 and inhibiting Aβ cascade pathogenesis
Chuang, Y. C., Van, I., Zhao, Y., & Xu, Y. (2021) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2021.102014 · Cited by 45
Pukhalskaia, A. E., Dyatlova, A., Linkova, N. S., Kozlov, K. L., Kvetnaia, T. V., Koroleva, M., & Kvetnoy, I. M. (2020) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-020-04986-4 · Cited by 40
Scuto, M. C., Modafferi, S., Rampulla, F., Zimbone, V., Tomasello, M., Spanò, S. M., Ontario, M. L., Palmeri, A., Salinaro, A. T., Siracusa, R., et al. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111686 · Cited by 43
Skawratananond, S., Xiong, D. X., Zhang, C., Tonk, S. S., Pinili, A., Delacruz, B., Pham, P., Smith, S. C., Navab, R., & Reddy, P. H. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102732 · Cited by 42
Resveratrol in Autism Spectrum Disorders: Behavioral and Molecular Effects
Malaguarnera, M., Khan, H. Z., & Cauli, O. (2020) · Antioxidants · doi:10.3390/antiox9030188 · Cited by 49
Zhu, L., Lu, F., Zhang, X., Liu, S., & Mu, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.877098 · Cited by 50
An, Y., Li, Y., Hou, Y., Huang, S., & Pei, G. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3086010 · Cited by 43
“Importantly, the protein level of SIRT1 is also decreased dramatically in AD mice brains and AD patients, which is closely related to the accumulation of Aβ and tau proteins than in normal aging individuals [26, 67].”
BackgroundLi, B., Chen, Y., Zhou, Y., Feng, X., Gu, G., Han, S., Cheng, N., Sun, Y., Zhang, Y., Cheng, J., et al. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385839 · Cited by 52
Deciphering therapeutic options for neurodegenerative diseases: insights from SIRT1
Wang, R., Wu, Y., Liu, R., Liu, M., Li, Q., Ba, Y., & Huang, H. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02187-2 · Cited by 39
“Furthermore, SIRT1 ameliorates neurodegeneration by attenuating pathological features and extending cell life span in both in vivo and in vitro models of neurodegenerative diseases [34, 200].”
BackgroundSirtuins family as a target in endothelial cell dysfunction: implications for vascular ageing
Zhang, H., Dai, Y., Zhang, C., Alfred, M. O., Ghosh, A., Khanra, I., Chakraborty, M., Yu, X., & Liang, J. L. (2020) · Biogerontology · doi:10.1007/s10522-020-09873-z · Cited by 37
New Insights into the Roles of p53 in Central Nervous System Diseases
Li, H., Zhang, Z., Li, H., Pan, X., & Wang, Y. (2023) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyad030 · Cited by 39
Ткаченко, Г. М., Buyun, L., Kołodziejska, R., Kamiński, P., & Kurhaluk, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188907 · Cited by 53
“…the dose–response relationship is a critical consideration for clinical translation, as many phytochemicals have narrow therapeutic windows that can vary depending on individual metabolic profiles, the composition of the gut microbiota, and genetic polymorphisms that affect drug metabolism [342].”
Resveratrol Alleviates Levodopa-Induced Dyskinesia in Rats
Zheng, C.-Q., Fan, H., Li, X., Li, J., Sheng, S., & Zhang, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.683577 · Cited by 35
Anti-Neuroinflammatory Potential of Natural Products in the Treatment of Alzheimer’s Disease
Deng, M., Yan, W., Gu, Z., Li, Y., Chen, L., & He, B. (2023) · Molecules · doi:10.3390/molecules28031486 · Cited by 41
Yao, K., Mou, Q., Lou, X., Ye, M., Zhao, B., Hu, Y., Luo, J., Zhang, H., Li, X., & Zhao, Y. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02886-8 · Cited by 35
Soybean isoflavones prevent atrazine-induced neurodegenerative damage by inducing autophagy
Li, P., Li, X., Yao, L., Wu, Y., & Li, B. (2019) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2019.110065 · Cited by 33
Chiu, K., Sun, Z., Liu, J., Luo, W., Wong, C.-H., So, K., & Hu, Y. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.314325 · Cited by 36
“For example, resveratrol has anti-inflammatory effects via the suppression of M1 microglia activation and the amelioration of proinflammatory cytokine release (Gomes et al., 2018).”
Block copolymers in Alzheimer's disease therapy: A perceptive to revolutionize biomaterials
Revdekar, A., & Shende, P. K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.007 · Cited by 36
Xiong, W., Li, D., Feng, Y., Jia, C., Zhang, X., & Liu, Z. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03177-8 · Cited by 33
“Resveratrol, an activator of SIRT1, has anti-oxidant and anti-inflammatory properties and can attenuate neuronal toxicity by decreasing Aβ aggregation in the hippocampus [29].”
BackgroundAlzheimer’s Amyloid-β Accelerates Cell Senescence and Suppresses SIRT1 in Human Neural Stem Cells
Li, R., Li, Y., Zuo, H., Pei, G., Huang, S., & Hou, Y. (2024) · Biomolecules · doi:10.3390/biom14020189 · Cited by 38
“There is growing evidence that SIRT1 plays a role in many processes in the onset and progression of AD, such as APP processing, neuroinflammation, and mitochondrial dysfunction [24,25].”
BackgroundMokarizadeh, N., Karimi, P., Erfani, M., Sadigh‐Eteghad, S., Maroufi, N. F., & Rashtchizadeh, N. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106300 · Cited by 36
Dong, Y., Cao, K., Xiang, J., Shan, L., & Guan, Z.-Z. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.03.015 · Cited by 34
Nargeh, H., Aliabadi, F., Ajami, M., & Pazoki–Toroudi, H. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c00923 · Cited by 33
Li, P., Yao, L., Jiang, Y., Wang, D., Wang, T., Wu, Y., Li, B., & Li, X. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112886 · Cited by 33
Wang, W., Li, X., Qian, Q., Yan, J., Huang, H., Wang, X., & Wang, H. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.131831 · Cited by 32
Nutraceuticals and Their Contribution to Preventing Noncommunicable Diseases
Garza-Juárez, A. D. J., Pérez‐Carrillo, E., Arredondo‐Espinoza, E., Islas, J. F., Chao, D. F. B., & Escamilla-García, E. (2023) · Foods · doi:10.3390/foods12173262 · Cited by 45
“Leukemia [90], cardiovascular diseases, SARS-CoV-2 infection [88], cancer [89], Metabolic syndrome [91], Alzheimer’s [92].”
BackgroundInfluentialMitochondrial DNA and Neurodegeneration: Any Role for Dietary Antioxidants?
Bordoni, L., & Gabbianelli, R. (2020) · Antioxidants · doi:10.3390/antiox9080764 · Cited by 35
Dave, B. P., Shah, Y. B., Maheshwari, K. G., Mansuri, M. K. A., Prajapati, B., Postwala, H. I., & Chorawala, M. R. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01408-7 · Cited by 38
The Beneficial Role of Sirtuin 1 in Preventive or Therapeutic Options of Neurodegenerative Diseases
Liu, H., Xu, S., Wang, C., Deng, Y. L., Xu, B., Yang, T., Sun, J., & Liu, W. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.09.021 · Cited by 32
Xiang, L., Wang, Y., Liu, S., Liu, B., Jin, X., & Cao, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411275 · Cited by 36
Anti-Aging Effect of Traditional Plant-Based Food: An Overview
Das, G., Kameswaran, S., Ramesh, B., Manjunatha, B., Nath, R., Talukdar, A. D., Shin, H., & Patra, J. K. (2024) · Foods · doi:10.3390/foods13233785 · Cited by 37
Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview
Štrac, D. Š., Konjevod, M., Šagud, M., Perković, M. N., Erjavec, G. N., Vuić, B., Šimić, G., Vukić, V., Mimica, N., & Pivac, N. (2021) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s284615 · Cited by 38
“The key neuroprotective mechanism of resveratrol in AD seems to be linked with SIRT1 activation.(158) Although, clinical trials are evaluating the potential of resveratrol in the prevention of cognitive impairment and cerebrovascular dysfunction in AD,(132,142)”
BackgroundAmyloid Precursor Protein: A Regulatory Hub in Alzheimer's Disease
Chen, J., Chen, J.-S., Li, S., Zhang, F., Deng, J., Zeng, L., & Tan, J. (2023) · Aging and Disease · doi:10.14336/ad.2023.0308 · Cited by 62
“[223, 224] Tg OE in APP/PS1 mice inhibits the amyloidogenic pathway, reduces plaque deposition and reduces GSK3β-dependent tau phosphorylation; [225] Protects against TBI; neuronal death during transient ischemia; and hypoxia in acute hippocampal slices; Stimulates aduit neurogenesis at the…”
BackgroundThe immunometabolic reprogramming of microglia in Alzheimerʼs disease
Chen, H., Guo, Z., Sun, Y., & Dai, X. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105614 · Cited by 31
Kamath, A. P., Nayak, P. G., John, J., Mutalik, S., Balaraman, A. K., & Nandakumar, K. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110096 · Cited by 37
Interaction between resveratrol and SIRT1: role in neurodegenerative diseases
Zhu, L., Yang, M., Fan, L., Yan, Q., Zhang, L., Mu, P., & Lu, F. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03319-w · Cited by 36
“SIRT1 attenuates the toxicity and aggregation of Aβ peptides in the hippocampus of AD patients to prevent hippocampal damage (Gomes et al. 2018).”
Li, Y., Lu, J. N., Cao, X., Zhao, H., Gao, L., Xia, P., & Pei, G. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7698560 · Cited by 46
“Indeed, a variety of antioxidants such as resveratrol [37, 38], curcumin [39], and idebenone have been shown to improve memory deficit in AD [40, 41].”
BackgroundLiu, J., Jiao, K., Zhou, Q., Yang, J., Yang, K., Hu, C., Zhou, M., & Li, Z. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6673343 · Cited by 32
“The phytochemical REV is a classical SIRT1 agonist, and the covalent binding of REV to SIRT1 alters the molecular conformation of SIRT1 and increases the affinity of the protein for its substrate [39, 40].”
BackgroundMeng, J., Zhu, Y., Ma, H., Wang, X., & Zhao, Q. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114464 · Cited by 32
Sabaie, H., Amirinejad, N., Asadi, M. R., Jalaiei, A., Daneshmandpour, Y., Rezaei, O., Taheri, M. N., & Rezazadeh, M. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.742242 · Cited by 30
New Insights into Microglial Mechanisms of Memory Impairment in Alzheimer’s Disease
Li, N., Deng, M., Hu, G., Li, N., Yuan, H., & Zhou, Y. (2022) · Biomolecules · doi:10.3390/biom12111722 · Cited by 35
Buccal Resveratrol Delivery System as a Potential New Concept for the Periodontitis Treatment
Paczkowska‐Walendowska, M., Dvořák, J., Rosiak, N., Tykarska, E., Szymańska, E., Winnicka, K., Ruchała, M. A., & Cielecka‐Piontek, J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030417 · Cited by 29
“In addition, the anti-diabetic and neuroprotective activity of stilbene have also been established [11,12].”
BackgroundPharmacological Treatment of Alzheimer’s Disease: Insights from Drosophila melanogaster
Cheng, X., Song, C., Du, Y., Gaur, U., & Yang, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134621 · Cited by 32
“Owing to the multiple targets, SIRT1 plays an important role in neurodegenerative diseases [91].”
BackgroundCong, P., Wang, T., Tong, C., Liu, Y., Shi, L., Mao, S., Shi, X., Jin, H., Liu, Y., & Hou, M. (2021) · Injury · doi:10.1016/j.injury.2021.08.019 · Cited by 28
Liao, H., Huang, J., Liu, J., Zhu, H., Chen, Y., Li, X., Wen, J., & Yang, Q. (2023) · Molecular Biology Reports · doi:10.1007/s11033-022-08167-6 · Cited by 28
Socała, K., Żmudzka, E., Lustyk, K., Zagaja, M. P., Brighenti, V., Costa, A., Andres‐Mach, M., Pytka, K., Martinelli, I., Mandrioli, J., et al. (2024) · Phytotherapy Research · doi:10.1002/ptr.8101 · Cited by 31
Vasei, F. M., Zamanian, M. Y., Golmohammadi, M., Mahmoodi, M., Khademalhosseini, M., Tavakoli, T., Esmaeili, O. S., Zarei, S., Mirzaei, M. R., & Hajizadeh, M. R. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4548 · Cited by 31
Güç, İ., Yalçın, E., Çavuşoğlu, K., & Acar, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-18791-8 · Cited by 30
Wan, C., Liu, X.-Q., Chen, M., Ma, H., Wu, G.-L., Qiao, L., Cai, Y.-F., & Zhang, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03889-y · Cited by 28
“Increasing evidences suggest that SIRT1 is involved in regulating multiple processes in AD progression, such as antineuroinflammation, anti-neurodegeneration, and improving the mitochondrial dysfunction [35, 36].”
BackgroundAn Insight into Molecular Mechanisms and Novel Therapeutic Approaches in Epileptogenesis
Singh, S., Singh, T. G., & Rehni, A. K. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200910153827 · Cited by 27
Neuroprotective expression of turmeric and curcumin
Abbas, S., Latif, M. S., Shafie, N. S., Ghazali, M. I., & Kormin, F. B. (2020) · Food Research · doi:10.26656/fr.2017.4(6).363 · Cited by 33
“Resveratrol Antioxidant; protection against neurodegenerative diseases and assembly of Aβ protein by activating SIRT1 longevity gene (Gomes et al., 2018); prevention of brain cell death in hippocampus (Kodali et al.”
BackgroundIbi, D., Kondo, S., Ohmi, A., Kojima, Y., Nakasai, G., Takaba, R., & Hiramatsu, M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03622-z · Cited by 27
“Notably, deacetylating and repressing p53 activities by SIRT1 contribute to the growth and differentiation of neurons and prevent neuronal apoptosis [53], leading to the neuroprotective effect against AD.”
BackgroundIn vitro Model Systems for Studies Into Retinal Neuroprotection
Zhu, Y., Cao, B., Tolone, A., Yan, J., Christensen, G., Arango‐González, B., Ueffing, M., & Paquet‐Durand, F. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.938089 · Cited by 30
“On the other hand, sirtuin-type HDACs (class III HDACs) are considered to be neuroprotective (Jiang et al., 2011; Gomes et al., 2018; Xu et al., 2018).”
BackgroundKhot, K. B., Gopan, G., Bandiwadekar, A., & Jose, J. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101806 · Cited by 29
Carrera, I., Martínez, O., & Cacabelos, R. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191202155738 · Cited by 27
Fekete, M., Jarecsny, T., Lehoczki, A., Major, D., Fazekas‐Pongor, V., Csípő, T., Lipécz, Á., Szappanos, Á., Pázmándi, E. M., Varga, P., et al. (2025) · Nutrients · doi:10.3390/nu17243929 · Cited by 31
“They also activate key signaling cascades involved in cellular stress resistance and brain aging, including SIRT1 [66–71].”
Kogut, Ł., Puchalski, C., Katryńska, D., & Zaguła, G. (2026) · Nutrients · doi:10.3390/nu18020313 · Cited by 37
“…come from preclinical studies and are mainly described in qualitative terms, without systematic analysis of the relationship between the effect and the dose and route of administration of resveratrol [92–94,98 In Alzheimer’s disease, resveratrol exhibits multidimensional neuroprotective effects.”
InfluentialUGT84F9 is the major flavonoid UDP-glucuronosyltransferase in Medicago truncatula
Adiji, O. A., Palacios, M. L. D., Alvarez‐Hernandez, A., Pasinetti, G. M., Wang, X., & Dixon, R. A. (2021) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiab016 · Cited by 24
PGC-1α activity and mitochondrial dysfunction in preterm infants
Mohammadi, A., Higazy, R., & Gauda, E. B. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.997619 · Cited by 27
“It has potent antioxidant, anti-inflammatory, and anti-apoptotic properties, and activates PGC-1α through the SIRT1 pathway (Tellone et al., 2015; Hoda et al., 2017; Gomes et al., 2018; Xuefei et al., 2021; Zhou et al., 2021).”
BackgroundZhang, J., Jian, P., Jiang, N., & Xu, L. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14463 · Cited by 28
Chitosan-Polyphenol Conjugates for Human Health
Pattnaik, A., Pati, S., & Samal, S. K. (2022) · Life · doi:10.3390/life12111768 · Cited by 27
“Polyphenols such as curcumin [39–41], resveratrol [42], quercetin [43], and catechins [44] show protective abilities against neurodegenerative diseases (Alzheimer’s-like diseases and dementia) through their antioxidant, immunomodulatory, and scavenging properties.”
BackgroundCK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders
Baier, A., & Szyszka, R. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.916063 · Cited by 24
Varshini, M. S., Krishnamurthy, P. T., Shaji, N., Mani, L., & Balasubramanian, S. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24933 · Cited by 26
“Stress, metabolic changes, and genomic instability lead to the overproduction of ROS by mitochondria (Gomes et al., 2018; Kausar et al., 2018).”
BackgroundSirtuins in intervertebral disc degeneration: current understanding
Shen, J., Lan, Y., Ji, Z., & Liu, H. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00811-0 · Cited by 27
Shandilya, S., Kesari, K. K., & Ruokolainen, J. (2021) · Antioxidants · doi:10.3390/antiox10060983 · Cited by 26
“Exogenous and some environmental factors or a natural aging process could cause an imbalance in oxidoredox homeostasis, resulting in the increase of ROS and RNS [48].”
BackgroundMou, Q., Yao, K., Ye, M., Zhao, B., Hu, Y., Lou, X., Li, H., Zhang, H., & Zhao, Y. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s338815 · Cited by 22
Sirtuins functions in central nervous system cells under neurological disorders
Yan, J., Tang, X., Zhou, Z., Zhang, J., Zhao, Y., Li, S., & Luo, A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.886087 · Cited by 26
“Sirtuin 1 (SIRT1) is a member of the nicotinamide adenine dinucleotide (NAD)+-dependent class III histone deacetylases, which is the studied one among the SIRT family (Gomes et al., 2018).”
BackgroundKhanna, A., Anamika, A., Chakraborty, S., Tripathi, S. J., Acharjee, A., Bs, S. R., & Trigun, S. K. (2020) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2020.101797 · Cited by 23
Isosteviol sodium protects the cardiomyocyte response associated with the SIRT1/PGC‐1α pathway
Mei, Y., Liu, B., Su, H., Zhang, H., Liu, F., Ke, Q., Sun, X., & Tan, W. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15715 · Cited by 22
Jin, B., Gao, Y., Fu, Y., Zhang, S., Zhang, K., & Su, Y. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003032 · Cited by 23
“42–44] Downregulation of SIRT-1 may lead to multiple sclerosis and other neurodegenerative disorders.”
BackgroundMedicinal herbal remedies in neurodegenerative diseases: an update on antioxidant potential
Sarkar, B., Rana, N., Singh, C., & Singh, A. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03027-5 · Cited by 31
“Resvera-trol’s antioxidant mechanisms, such as SIRT1 activation, A aggregation, and toxicity inhibition, metal chelation, and reactive oxygen species scavenging, were also reported (Gomes, et al. 2018).”
Gao, S., Tang, Y.-Y., Jiang, L., Lan, F., Li, X., Zhang, P., Zou, W., Chen, Y., & Tang, X. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03314-0 · Cited by 22
Promising protein biomarkers in the early diagnosis of Alzheimer’s disease
Sharma, L. K., Sharma, A., Kumar, D., Asthana, M. K., Lalhlenmawia, H., Kumar, A., Bhattacharyya, S., & Kumar, D. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-021-00847-9 · Cited by 27
“SIRT1 is crucial for neuronal growth and differentiation, and preventing apoptosis by deacetylating and downregulating p53 however, the exact mechanistic pathway is still unknown (Gomes et al. 2018).”
BackgroundGao, Q., Zhao, Y. F., Luo, R., Su, M., Zhang, C., Li, C., Liu, B., & Zhou, X. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122045 · Cited by 22
Mohammadi, S., Moghadam, M. D., Nasiriasl, M., Akhzari, M., & Barazesh, M. (2024) · Current Clinical Pharmacology · doi:10.2174/0127724328268507231218051058 · Cited by 22
Zhang, Y., Wei, R., Zhang, J., Liu, S., Zhang, K., Kong, X., Ge, Y., Li, X., & Chen, G. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23698 · Cited by 22
Parlar, A., & Arslan, S. O. (2019) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2019.06.027 · Cited by 21
The role of resveratrol as a natural modulator in glia activation in experimental models of stroke.
Ghazavi, H., Shirzad, S., Forouzanfar, F., Negah, S. S., Rad, M. R., & Vafaee, F. (2020) · PubMed Central · doi:10.22038/ajp.2020.15529 · Cited by 24
Has resveratrol a potential for mucopolysaccharidosis treatment?
Rintz, E., Pierzynowska, K., Podlacha, M., & Węgrzyn, G. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173534 · Cited by 22
AlHayani, D. A., Kubaev, A., Uthirapathy, S., Mandaliya, V. B., Ballal, S., Kalia, R., Arya, R., Gabble, B. C., Alasheqi, M. Q., & KADHIM, A. J. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02324-9 · Cited by 23
“Overall, the action mechanism of SIRT1 activation by resveratrol often falls into one of two categories: (1) management of oxidative stress and (2) its anti-inflammatory role (Gomes et al. 2018).”
Czapski, G. A., Zhao, Y., Lukiw, W. J., & Strosznajder, J. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217838 · Cited by 20
“Recent studies have demonstrated the significant role of seven proteins from S100 family, including S100a8 and S100a9, in the pathomechanism of AD [57].”
BackgroundMultifaced role of protein deacetylase sirtuins in neurodegenerative disease
Gupta, R. V., Ambasta, R. K., & Kumar, P. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.10.047 · Cited by 21
Pérez-Arancibia, R., Cisternas-Olmedo, M., Sepúlveda, D., Troncoso-Escudero, P., & Vidal, R. L. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1084493 · Cited by 23
“Its neuroprotective properties have also been analyzed and several mechanisms of action of this molecule have been described (Bastianetto et al., 2015; Kou and Chen, 2017; Gomes et al., 2018; Lin et al., 2018).”
BackgroundKong, A. H.-Y., Wu, A. J., Ho, O. K.-Y., Leung, M. M.-K., Huang, S., Yu, Y., Zhang, G., Lü, A., Li, M., & Cheung, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411780 · Cited by 27
“and it has been found to preserve the integrity of the blood–brain barrier (BBB) [89,90].”
BackgroundProtective Effects of Polydatin Against Dementia-Related Disorders
Tang, K. S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200611144825 · Cited by 32
“Although the mechanistic insights of resveratrol in AD have extensively been reviewed [2, 3, 17-19], the comparative literature of its role with other stilbenes including polydatin is still lacking.”
BackgroundThe Potential Application of Resveratrol and Its Derivatives in Central Nervous System Tumors
Nowacka, A., Śniegocka, M., Smuczyński, W., Liss, S., Ziółkowska, E., Bożiłow, D., Śniegocki, M., & Wiciński, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413338 · Cited by 22
Lei, K., Zhou, L., Dan, M., Yang, F., Jian, T., Xin, J., Yu, Z., & Wang, Y. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030280 · Cited by 22
“Resveratrol regulates oxidative stress and anti-inflammatory responses by activating the Sirt1 pathway and inhibits A β peptide aggregation, showing significant effects on AD neuroinflammation and neuronal apoptosis when combined with exercise therapy [113,114].”
Polyphenols in the Central Nervous System: Cellular Effects and Liposomal Delivery Approaches
Kaluza, M., Ksiazek-Winiarek, D. J., Szpakowski, P., Czpakowska, J., Fijalkowska, J., & Glabinski, A. R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136477 · Cited by 30
“It is suggested that resveratrol influences microglia by acting on SIRT1, which leads to an intensified Th2 response, alleviating inflammation [165].”
Sirt‐1 Regulates Physiological Process and Exerts Protective Effects against Oxidative Stress
Liu, L., Xia, G., Li, P., Wang, Y., & Zhao, Q. L. (2021) · BioMed Research International · doi:10.1155/2021/5542545 · Cited by 21
“Overexpression of Sirt-1 enhanced cell viability and cell proliferation by promoting the entry of cell cycle from the G1 phase to the G0 phase, which is consistent with previous studies [38, 39].”
ResultZeini, S., Davoodian, N., Kazemi, H., Brojeni, M. S., Ghani, E., Firouzjaei, M. A., & Atashabparvar, A. (2024) · Physiology & Behavior · doi:10.1016/j.physbeh.2024.114508 · Cited by 21
Komorowska, J., Wątroba, M., Bednarzak, M., Grabowska, A. D., & Szukiewicz, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063110 · Cited by 24
Vassal, M., Martins, F., Monteiro, B., Tambaro, S., Martínez-Murillo, R., & Rebelo, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04246-w · Cited by 20
Subramanian, A., Tamilanban, T., Subramaniyan, V., Sekar, M., Kumar, V., Janakiraman, A. K., & Kayarohanam, S. (2024) · Toxicology Reports · doi:10.1016/j.toxrep.2024.101715 · Cited by 26
A Review of ApoE4 Interference Targeting Mitophagy Molecular Pathways for Alzheimer's Disease
Chen, H., Chen, F., Jiang, Y., Zhang, L., Hu, G., Sun, F., Zhang, M., Ji, Y., Chen, Y., Che, G., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.881239 · Cited by 19
Metadata
- Authors
- Gomes, B. A. Q., Silva, J. P. B., Romeiro, C. F. R., dos Santos, S. M., Rodrigues, C. A., Gonçalves, P. R., Sakai, J. T., Mendes, P. F. S., Varela, E. L. P., & Monteiro, M. C.
- Affiliations
- Universidade Federal do Pará (BR)
- Corresponding author
- Monteiro, Marta Chagas
- ORCID
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2018-01
- Volume
- 2018
- Issue
- 1
- Pages
- 8152373-8152373
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- PMC
- PMC6232815
- OpenAlex
- W2898838755
- Cited by
- 403
- References
- 170
- Citations by year
- 2026: 40 · 2025: 52 · 2024: 52 · 2023: 58 · 2022: 58 · 2021: 54 · 2020: 64 · 2019: 24
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Oxidative Medicine and Cellular Longevity (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação Amazônia Paraense de Amparo à Pesquisa
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- resveratrol, Alzheimer's disease, SIRT1, neuroprotection, amyloid-beta aggregation, antioxidant activity, anti-inflammatory activity, microglial activation, M1 microglia, Th2 immune response, p53 deacetylation, neuronal apoptosis, neurogenesis, hippocampus
- MeSH terms
- Resveratrol, Alzheimer Disease, Animals, Antioxidants, Humans, Neuroprotective Agents, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.